Hisense Home Appliances Group Co., Ltd. - 0921.HK

0921.HK Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
0921.HK	-1.6	2.6	13.3	2.8	19.3	47.2	145.0	184.8	346.6	385.7
S&P 500	1.0	3.7	2.2	2.3	8.9	23.9	32.3	80.6	196.5	33856.2

Compare 0921.HK with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	0921.HK
name	Hisense Home Appliances Group Co., Ltd.
price	27.2
changes percentage	-1.6275
change	-0.45
day low	27
day high	27.6
year high	39.5
year low	17.6
market cap	42221417355
price avg 50	24.403
price avg 200	26.6469
exchange	HKSE
volume	1674100
avg volume	2923024
open	27.6
previous close	27.65
eps	2.5
pe	10.88
earnings announcement	2025-03-27T10:59:00.000+0000
shares outstanding	1552257991
timestamp	2025-01-17 08:08:13

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 40.7%

Overall Quarterly Financial Health: 21.7%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
revenue	85600189223	74115151039	15.50
gross profit	18904072992	15332031839	23.30
gross profit ratio	0.22	0.21	6.75
research and development expenses	2779508194	2289313746	21.41
operating expenses	13656056598	12257686443	11.41
interest income	43980886	79204113	-44.47
interest expense	144388196	88136778	63.82
ebitda	7039985870	5270502052	33.57
ebitdaratio	0.08	0.08	7.29
operating income	5248016394	3367104322	55.86
operating income ratio	0.06	0.05	34.95
net income	2837322754	3069234330	-7.56
net income ratio	0.03	0.04	-19.96
eps	2.08	2.25	-7.56

Overall Score of Annual Income Statement

0.62 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 85,600 million in 2023 from 74,115 million in 2022 representing a change of 15.5%. This indicates a sales growth, which is a positive sign for the company.

  Gross Profit: Gross Profit increased to 18,904 million in 2023 from 15,332 million in 2022 representing a change of 23.3%. This indicates a sales profitability growth, which is a positive sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses increased to 2,780 million in 2023 from 2,289 million in 2022 representing a change of 21.41%. This shows that the company continues to invest in innovation and product development, which is crucial for long-term growth.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 7,040 million in 2023 from 5,271 million in 2022 representing a change of 33.57%. The increase in EBITDA indicates improved operational efficiency and profitability.

  Operating Income: Operating income increased to 5,248 million in 2023 from 3,367 million in 2022 representing a change of 55.86%. The increase in operating income indicates better operational performance and increased profitability.

• 📉 Negative Indicators

  Operating Expenses: Operating Expenses increased to 13,656 million in 2023 from 12,258 million in 2022 representing a change of 11.41%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

  Net Income: Net income decreased to 2,837 million in 2023 from 3,069 million in 2022 representing a change of -7.56%. The decrease in net income shows worsen profitability and indicates that the company is generating less profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 2.08 in 2023 from 2.08 in 2022 representing a change of -7.56%. This indicates that the company's earnings are decreasing and it is becoming less profitable on a per-share basis.

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0000000000
revenue	21937415143	25155554080	-12.79
gross profit	4555037846	5270224410	-13.57
gross profit ratio	0.21	0.21	-0.89
research and development expenses	822164456	869794879	-5.48
operating expenses	3343847862	3594529971	-6.97
interest income	15491379	234244483	-93.39
interest expense	40234542	0	NaN
ebitda	1326699779	1659569007	-20.06
ebitdaratio	0.06	0.07	-8.33
operating income	1211189982	1675694439	-27.72
operating income ratio	0.06	0.07	-17.12
net income	777159401	1034584593	-24.88
net income ratio	0.04	0.04	-13.86
eps	0.58	0.76	-23.68

Overall Score of Quarterly Income Statement

0.25 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Revenue Growth: revenue decreased to 21,937 million in 2024Q3 from 25,156 million in 2024Q2 representing a change of -12.79%. This indicates a sales shrinking, which is a negative sign for the company.

  Gross Profit: Gross Profit decreased to 4,555 million in 2024Q3 from 5,270 million in 2024Q2 representing a change of -13.57%. This indicates a sales profitability decline, which is a negative sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses decreased to 822 million in 2024Q3 from 870 million in 2024Q2 representing a change of -5.48%. This shows that the company decreased investment in innovation and product development, which is not a good sign for long-term growth.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to 1,327 million in 2024Q3 from 1,660 million in 2024Q2 representing a change of -20.06%. The decrease in EBITDA indicates declined operational efficiency and profitability.

  Operating Income: Operating income decreased to 1,211 million in 2024Q3 from 1,676 million in 2024Q2 representing a change of -27.72%. The decrease in operating income indicates worse operational performance and decreased profitability.

  Earnings per Share (EPS): EPS increased to 0.58 in 2024Q3 from 0.58 in 2024Q2 representing a change of -23.68%. This indicates that the company's earnings are decreasing and it is becoming less profitable on a per-share basis.

• 📈 Positive Indicators

  Operating Expenses: Operating Expenses decreased to 3,344 million in 2024Q3 from 3,595 million in 2024Q2 representing a change of -6.97%. The decrease in operating expenses can be attributed to various factors such as improved profitability, cost optimization and financial stability, lower operating expenses can be positive indicators.

  Net Income: Net income increased to 777 million in 2024Q3 from 1,035 million in 2024Q2 representing a change of -24.88%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
total assets	65946495555	55375550868	19.09
total liabilities	46550436429	39096785837	19.06
total equity	19396059125	16278765030	19.15
cash and cash equivalents	4939273198	6001295427	-17.70
short term investments	13192025535	6758233998	95.20
long term investments	-11453217841	-5177745482.03	-121.20
total current assets	45139919481	36629189836	23.23
total non current assets	20806576074	18746361031	10.99
total current liabilities	44042092245	36364942204	21.11
total non current liabilities	2508344179	2731843632	-8.18
common stock	1387935370	1362725370	1.85
retained earnings	9355458114	7248124550	29.07
total debt	2754221050	1904427933	44.62

Overall Score of Annual Balance Sheet

0.6 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 65,946 million in 2023 from 55,376 million in 2022 representing a change of 19.09%. Suggesting a growth in asset holdings.

  Total Equity: Total Equity increased to 19,396 million in 2023 from 16,279 million in 2022 representing a change of 19.15%. This indicates an increase in shareholders' equity.

  Short Term Investments: Short Term Investments increased to 13,192 million in 2023 from 6,758 million in 2022 representing a change of 95.2%. This indicates an increase in short-term investment holdings.

  Total Current Assets: Total Current Assets increased to 45,140 million in 2023 from 36,629 million in 2022 representing a change of 23.23%. This indicates a better liquidity position.

  Common Stock: Common Stock increased to 1,388 in 2023 from 1,363 in 2022 representing a change of 1.85%. This indicates an increase in ownership interest.

  Retained Earnings: Retained Earnings increased to 9,355 million in 2023 from 7,248 million in 2022 representing a change of 29.07%. This indicates an accumulated profits.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 46,550 million in 2023 from 39,097 million in 2022 representing a change of 19.06%. This indicates an increase in overall liabilities.

  Cash And Cash Equivalents: Cash And Cash Equivalents decreased to 4,939 million in 2023 from 6,001 million in 2022 representing a change of -17.7%. This indicates a decrease in available liquid assets.

  Total Current Liabilities: Total Current Liabilities increased to 44,042 million in 2023 from 36,365 million in 2022 representing a change of 21.11%. This indicates a higher short-term debt burden.

  Total Debt: Total Debt increased to 2,754 million in 2023 from 1,904 million in 2022 representing a change of 44.62%. This indicates an increase in overall debt burden.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0000000000
total assets	68561423626	70721704541	-3.05
total liabilities	50241652486	51709057690	-2.84
total equity	18319771139	19012646851	-3.64
cash and cash equivalents	4760576869	5219471325	-8.79
short term investments	15540453733	2948510758	427.06
long term investments	-13637416616	11499481071	-218.59
total current assets	49243705036	49925281720	-1.37
total non current assets	19317718589	20796422821	-7.11
total current liabilities	47770258825	49269895312	-3.04
total non current liabilities	2471393660	2439162378	1.32
common stock	1386010405	1387167370	-0.08
retained earnings	10745175962	10691222457	0.50
total debt	3013818991	2640390065	14.14

Overall Score of Quarterly Balance Sheet

0.4 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Total Assets: Total Assets decreased to 68,561 million in 2024Q3 from 70,722 million in 2024Q2 representing a change of -3.05%. Suggesting a decrease in asset holdings.

  Total Equity: Total Equity decreased to 18,320 million in 2024Q3 from 19,013 million in 2024Q2 representing a change of -3.64%. This indicates a decrease in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents decreased to 4,761 million in 2024Q3 from 5,219 million in 2024Q2 representing a change of -8.79%. This indicates a decrease in available liquid assets.

  Total Current Assets: Total Current Assets decreased to 49,244 million in 2024Q3 from 49,925 million in 2024Q2 representing a change of -1.37%. This indicates a worsen liquidity position.

  Common Stock: Common Stock decreased to 1,386 in 2024Q3 from 1,387 in 2024Q2 representing a change of -0.08%. This indicates a decrease in ownership interest.

  Total Debt: Total Debt increased to 3,014 million in 2024Q3 from 2,640 million in 2024Q2 representing a change of 14.14%. This indicates an increase in overall debt burden.

• 📈 Positive Indicators

  Total Liabilities: Total Liabilities decreased to 50,242 million in 2024Q3 from 51,709 million in 2024Q2 representing a change of -2.84%. This indicates a decrease in overall liabilities.

  Short Term Investments: Short Term Investments increased to 15,540 million in 2024Q3 from 2,949 million in 2024Q2 representing a change of 427.06%. This indicates an increase in short-term investment holdings.

  Total Current Liabilities: Total Current Liabilities decreased to 47,770 million in 2024Q3 from 49,270 million in 2024Q2 representing a change of -3.04%. This indicates a lower short-term debt burden.

  Retained Earnings: Retained Earnings increased to 10,745 million in 2024Q3 from 10,691 million in 2024Q2 representing a change of 0.5%. This indicates an accumulated profits.

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
net change in cash	398794325	-400830719	199.49
operating cash flow	10611857591	4032382602	163.17
free cash flow	9626738478	3148897938	205.72
capital expenditure	-985119113	-883484663.15	-11.50
depreciation and amortization	1211040252	1358555546	-10.86
deferred income tax	0	0	NaN
stock based compensation	0	0	NaN
accounts payables	1837172947	658220353	179.11
inventory	-200738889.61	1835856733	-110.93
acquisitions net	12399066	56397893	-78.02
investments in property plant and equipment	-985119113	-883484663.15	-11.50
net cash used for investing activites	-9557443577	-2597645960.92	-267.93
debt repayment	947216020	-1405467223	167.40
common stock issued	0	0	NaN
common stock repurchased	0	0	NaN
dividends paid	-813556178.26	-364653655.03	-123.10
net cash used provided by financing activities	-621138710	-1778631506.86	65.08
cash at end of period	2877140400	2478346075	16.09
accounts receivables	-1837172947	-658220353	-179.11
cash at beginning of period	2478346075	2879176794	-13.92

Overall Score of Annual Cashflow Statement

None

Detailed Analysis

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0000000000
operating cash flow	0	1943924312	-100.00
free cash flow	2630564921	1654623146	58.98
capital expenditure	-477051739.49	-289301166	-64.90
depreciation and amortization	0	609779964	-100.00
deferred income tax	0	0	NaN
stock based compensation	0	0	NaN
accounts receivables	0	0	NaN
accounts payables	0	0	NaN
inventory	0	0	NaN
acquisitions net	0	0	NaN
investments in property plant and equipment	-477051739.49	-289301165.86	-64.90
net cash used for investing activites	-1739161465.24	-193457757	-798.99
debt repayment	311104672	18942552	1542.36
common stock issued	0	0	NaN
common stock repurchased	0	0	NaN
dividends paid	-1422753097.78	-26926891	-5183.76
net cash used provided by financing activities	-1905840408.97	-2069599460	7.91
net change in cash	-485339789.21	-364053127	-33.32
cash at end of period	2264376345	2749716134	-17.65
cash at beginning of period	2749716134	3113769261	-11.69

Overall Score of Quarterly Cashflow Statement

None

Detailed Analysis

Earnings Transcripts ⓘ

No earnings transcripts available.

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2023-12-31	2022-12-31	Y/Y change %
FY
calendar year	2023	2022	NaN
revenue per share	62.75	54.39	15.38
net income per share	2.08	2.25	-7.65
operating cash flow per share	7.78	2.96	162.90
free cash flow per share	7.06	2.31	205.41
cash per share	13.29	9.36	41.96
book value per share	14.22	11.95	19.03
tangible book value per share	13.07	10.71	22.05
shareholders equity per share	9.96	8.45	17.78
interest debt per share	2.12	1.46	45.32
market cap	27923075374.66	17947093122.9	55.59
enterprise value	25738023226.66	13850225628.9	85.83
pe ratio	9.84	5.85	68.30
price to sales ratio	0.33	0.24	34.71
pocfratio	2.63	4.45	-40.88
pfcf ratio	2.9	5.7	-49.11
pb ratio	2.06	1.56	31.96
ptb ratio	2.06	1.56	31.96
ev to sales	0.3	0.19	60.90
enterprise value over ebitda	3.84	2.77	38.88
ev to operating cash flow	2.43	3.43	-29.39
ev to free cash flow	2.67	4.4	-39.21
earnings yield	0.1	0.17	-40.58
free cash flow yield	0.34	0.18	96.49
debt to equity	0.2	0.17	22.66
debt to assets	0.04	0.03	21.44
net debt to ebitda	-0.33	-0.82	60.14
current ratio	1.02	1.01	1.75
interest coverage	36.35	38.2	-4.86
income quality	2.21	1.31	68.57
dividend yield	0.03	0.02	79.31
payout ratio	0.29	0.1	201.78
sales general and administrative to revenue	0.03	0.02	9.16
research and ddevelopement to revenue	0.03	0.03	5.12
intangibles to total assets	0.02	0.03	-21.89
capex to operating cash flow	0.09	0.22	-57.63
capex to revenue	0.01	0.01	-3.46
capex to depreciation	0.81	0.65	25.09
stock based compensation to revenue	0	0	NaN
graham number	21.59	20.7	4.29
roic	0.18	0.21	-14.86
return on tangible assets	0.04	0.06	-22.90
graham net net	-10.22	-9.83	-3.96
working capital	1097827236	264247632	315.45
tangible asset value	17827794322	14592739806	22.17
net current asset value	-1410516948	-2467596001	42.84
invested capital	8941561347	7974911350	12.12
average receivables	13840911470.5	12777490068	8.32
average payables	16544907633.5	22166587216.5	-25.36
average inventory	6663719436.5	7494767247	-11.09
days sales outstanding	63.07	63.48	-0.64
days payables outstanding	65.94	130.64	-49.52
days of inventory on hand	37.07	40.69	-8.88
receivables turnover	5.79	5.75	0.64
payables turnover	5.54	2.79	98.11
inventory turnover	9.85	8.97	9.75
roe	0.21	0.27	-21.59
capex per share	0.72	0.65	11.39

• Neutral

  ROE: Return on Equity (ROE) decreased to 0.21 on 2023-12-31 from 0.27 on 2022-12-31, representing a change of -21.59%. However, ROE is >= 15%, suggesting that the company has been generating high returns for its shareholders still.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio increased to 0.20 on 2023-12-31 from 0.17 on 2022-12-31, representing a change of 22.66%. The debt-to-equity ratio has been increasing, indicating that the company has been relying more on debt financing. Higher leverage may increase financial risk. However, a ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 9.84 on 2023-12-31 from 5.85 on 2022-12-31, representing a change of 68.30%. Indicating an increase in the relative valuation of the company's stock.

  Current Ratio: Current Ratio increased to 1.02 on 2023-12-31 from 1.01 on 2022-12-31, representing a change of 1.75%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Also, it's above 1, indicating the ability to cover short-term obligations.

• Quarterly Financial Ratios

	2024-09-30 Q3	2024-06-30 Q2	Q/Q change %
0921.HK
calendar year	2024	2024	NaN
revenue per share	16.26	18.55	-12.35
net income per share	0.58	0.77	-24.82
operating cash flow per share	2.37	1.57	51.57
free cash flow per share	1.95	1.35	44.30
cash per share	15.05	16.37	-8.07
book value per share	13.58	14.19	-4.32
tangible book value per share	12.34	13.06	-5.47
shareholders equity per share	10.96	10.49	4.54
interest debt per share	2.26	17.99	-87.42
market cap	47893064768	42924682141.99	11.57
enterprise value	46146306890	61966328464.99	-25.53
pe ratio	15.41	10.37	48.53
price to sales ratio	2.18	1.71	27.40
pocfratio	14.96	20.31	-26.32
pfcf ratio	18.21	23.53	-22.61
pb ratio	3.24	3.03	6.82
ptb ratio	3.24	3.03	6.82
ev to sales	2.1	2.47	-14.97
enterprise value over ebitda	34.78	31.69	9.76
ev to operating cash flow	14.42	29.31	-50.82
ev to free cash flow	17.54	33.96	-48.35
earnings yield	0.02	0.02	-32.67
free cash flow yield	0.05	0.04	29.22
debt to equity	0.2	1.71	-88.11
debt to assets	0.04	0.34	-87.19
net debt to ebitda	-1.32	9.74	-113.52
current ratio	1.03	1.01	1.73
interest coverage	30.1	34.68	-13.21
income quality	4.12	2.04	101.60
dividend yield	0.03	0.0	4635.63
payout ratio	1.83	0.03	6933.95
sales general and administrative to revenue	0.03	0.02	14.41
research and ddevelopement to revenue	0.04	0.03	7.93
intangibles to total assets	0.02	0.02	12.27
capex to operating cash flow	0.15	0.14	8.89
capex to revenue	0.02	0.01	88.29
capex to depreciation	0	0.95	-100.00
stock based compensation to revenue	0	0	NaN
graham number	11.92	13.45	-11.35
roic	0.05	0.04	12.84
return on tangible assets	0.01	0.01	-22.30
graham net net	-10.54	-8.32	-26.74
working capital	1473446211	655386407	124.82
tangible asset value	16650263681	17629119334	-5.55
net current asset value	-997947450	-1633454697	38.91
invested capital	9440737348	8330813289	13.32
average receivables	18533799723	19109411402	-3.01
average payables	16600128786.5	5942656381.5	179.34
average inventory	6148673386.5	6918339549	-11.13
days sales outstanding	70.56	71.39	-1.17
days payables outstanding	148.1	20.8	612.05
days of inventory on hand	29.23	30.1	-2.89
receivables turnover	1.28	1.26	1.18
payables turnover	0.61	4.33	-85.96
inventory turnover	3.08	2.99	2.98
roe	0.05	0.07	-28.08
capex per share	0.35	0.21	65.04

• Negative

  ROE: Return on Equity (ROE) decreased to 0.05 on 2024-09-30 Q3 from 0.07 on 2024-06-30 Q2, representing a change of -28.08%. Suggesting that the company has not been generating high returns for its shareholders.

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 15.41 on 2024-09-30 Q3 from 10.37 on 2024-06-30 Q2, representing a change of 48.53%. Indicating an increase in the relative valuation of the company's stock.

  Current Ratio: Current Ratio increased to 1.03 on 2024-09-30 Q3 from 1.01 on 2024-06-30 Q2, representing a change of 1.73%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Also, it's above 1, indicating the ability to cover short-term obligations.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.20 on 2024-09-30 Q3 from 1.71 on 2024-06-30 Q2, representing a change of -88.11%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

None